| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Eidel Jeff serves as a See Remarks at PACB. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $1.4M at current prices.
Historically, Eidel Jeff's trades have earned a strong insider score of 76/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +57.2%.
The biggest single holding is PACB (~$1.4M) as See Remarks. The recent filings there lean toward selling, a net 68,194 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | PACB Pacific Biosciences Of California, Inc. | See Remarks | Sell | 26,760 | $1.59 | $42,601.92 | -3.0% | -1.9% | -18.8% | |
| Feb 16, 2024 | PACB Pacific Biosciences Of California, Inc. | See Remarks | Sell | 15,498 | $5.96 | $92,337.08 | -3.5% | -61.8% | -67.8% | |
| Aug 17, 2023 | PACB Pacific Biosciences Of California, Inc. | See Remarks | Sell | 25,936 | $10.60 | $274,843.79 | -5.5% | -25.6% | -85.1% |